Month: July 2022

Today I’m looking at REITs to sell now, as they have little or no income and their prospects for investors are not that good as a result. Moreover, it may take some time for these REITs, or real estate investment trusts, to revive and renew their ability to produce income for their investors. The fact
0 Comments
With shares of casino giant Wynn Resorts (WYNN) tanking in the wake of its latest earnings report, Ryan McQueeney explains how growth & income investors can find better options by focusing on REITs that own gaming properties. Wynn: https://www.zacks.com/stock/quote/WYNN?cid=CS-YOUTUBE-FT-VID Gaming and Leisure Properties: https://www.zacks.com/stock/quote/GLPI?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like
0 Comments
Tracey Ryniec uncovers two top stocks that are flying under the radar. Natus Medical Inc.: https://www.zacks.com/stock/quote/BABY?cid=CS-YOUTUBE-FT-VID Coherent Inc: https://www.zacks.com/stock/quote/COHR?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
0 Comments
JEasily one of the top-performing sectors for the first few months of this year, the best natural gas stocks to buy have suffered a conspicuous loss of momentum. Arguably, the erosion stems from global recession fears and subsequent governmental responses that wouldn’t be bullish for rising demand. Still, bold contrarian speculators may have an opportunity
0 Comments
Undoubtedly, one of the most remarkable phenomena that impacted the equities market following the coronavirus pandemic was the rise of the meme trader. Leveraging the psychology of the masses, everyday folks — often inspired by the people-versus-the-elites narrative — coordinated their efforts via social media, creating dramatic upside. Now, investors who missed the boat have
0 Comments
Biogen Inc. (NASDAQ:BIIB – Get Rating) – Equities research analysts at Jefferies Financial Group increased their FY2022 earnings per share (EPS) estimates for Biogen in a research note issued on Wednesday, July 20th. Jefferies Financial Group analyst M. Yee now forecasts that the biotechnology company will post earnings of $16.62 per share for the year,
0 Comments
Investing isn’t for the faint of heart at this time, with inflation rates near 40-year highs and the Federal Reserve raising interest rates aggressively. The U.S. is on the verge of a recession, while the S&P 500 entered bear market territory recently. Investors are re-evaluating their strategies and looking to avoid selling stocks in a
0 Comments
Snap (NYSE:SNAP – Get Rating) had its target price reduced by research analysts at KeyCorp from $27.00 to $25.00 in a research report issued to clients and investors on Thursday, Stock Target Advisor reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s price objective would indicate a potential upside of 151.00% from
0 Comments
In today’s episode of let’s talk stocks, I’m going to show you how to find the perfect inner balance between trading and your personal life. So that you understand when to trade, how much to trade and when you should not trade in the stock market. Posted at: https://tradersfly.com/blog/inner-balance-with-trading-ep-232/ ? Newsletter & Announcements : https://tradersfly.com/go/tube/
0 Comments
Click here for 7-free handpicked stocks: https://www.zacks.com/bull Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments